Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure

Journal of Molecular Medicine

Volumn 88, Issue 10, 2010, Pages 1011-1020

  Piao, Lin ^a   Marsboom, Glenn ^a   Archer, Stephen L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Action potential duration; Dichloroacetate; Fatty acid oxidation inhibitors; Myc; Pyruvate dehydrogenase kinase

Indexed keywords

DICHLOROACETIC ACID; MONOCROTALINE;

ENERGY TRANSFER; GLUCOSE OXIDATION; GLYCOLYSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE HYPERTROPHY; MITOCHONDRIAL RESPIRATION; NONHUMAN; PULMONARY HYPERTENSION; RAT; REVIEW;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; FATTY ACIDS; GLUCOSE; HEART FAILURE; HUMANS; HYPERTROPHY, RIGHT VENTRICULAR; MITOCHONDRIA; OXIDATION-REDUCTION; OXYGEN;

EID: 78149415338     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-010-0679-1     Document Type: Review

References (53)

1. B Sztrymf R Souza L Bertoletti X Jais O Sitbon LC Price G Simonneau M Humbert 2010 Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension Eur Respir J 35 1286 1293 1:STN:280: DC%2BC3czntlOjtQ%3D%3D 10.1183/09031936.00070209 19897557
2. A Gavazzi C Berzuini C Campana C Inserra M Ponzetta R Sebastiani S Ghio F Recusani 1997 Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure J Heart Lung Transplant 16 774 785 1:STN:280:DyaK2svgtFCmtg%3D%3D 9257260
3. SA van Wolferen JT Marcus A Boonstra KM Marques JG Bronzwaer MD Spreeuwenberg PE Postmus A Vonk-Noordegraaf 2007 Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension Eur Heart J 28 1250 1257 10.1093/eurheartj/ehl477 17242010 (Pubitemid 47343830)
4. A Gomez D Bialostozky A Zajarias E Santos A Palomar ML Martinez J Sandoval 2001 Right ventricular ischemia in patients with primary pulmonary hypertension J Am Coll Cardiol 38 1137 1142 1:STN:280:DC%2BD3Mrjs1WntA%3D%3D 10.1016/S0735-1097(01)01496-6 11583894 (Pubitemid 32912723)
5. SA van Wolferen JT Marcus N Westerhof MD Spreeuwenberg KM Marques JG Bronzwaer IR Henkens CT Gan A Boonstra PE Postmus A Vonk-Noordegraaf 2008 Right coronary artery flow impairment in patients with pulmonary hypertension Eur Heart J 29 120 127 10.1093/eurheartj/ehm567 18065750
6. X Bian AG Williams Jr PA Gwirtz HF Downey 1998 Right coronary autoregulation in conscious, chronically instrumented dogs Am J Physiol 275 H169 H175 1:CAS:528:DyaK1cXkvFaru70%3D 9688910
7. HJ Bogaard R Natarajan SC Henderson CS Long D Kraskauskas L Smithson R Ockaili JM McCord NF Voelkel 2009 Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure Circulation 120 1951 1960 10.1161/CIRCULATIONAHA.109.883843 19884466
8. M Oikawa Y Kagaya H Otani M Sakuma J Demachi J Suzuki T Takahashi J Nawata T Ido J Watanabe K Shirato 2005 Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol J Am Coll Cardiol 45 1849 1855 1:CAS:528:DC%2BD2MXpsVCqt7g%3D 10.1016/j.jacc.2005.02.065 15936618 (Pubitemid 40779867)
9. L Piao YH Fang VJ Cadete C Wietholt D Urboniene PT Toth G Marsboom HJ Zhang I Haber J Rehman GD Lopaschuk SL Archer 2010 The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle J Mol Med 88 47 60 1:CAS:528:DC%2BC3cXlvFChtQ%3D%3D 10.1007/s00109-009-0524-6 19949938
10. N Handa Y Magata T Mukai T Nishina J Konishi M Komeda 2007 Quantitative FDG-uptake by positron emission tomography in progressive hypertrophy of rat hearts in vivo Ann Nucl Med 21 569 576 10.1007/s12149-007-0067-2 18092133 (Pubitemid 350293598)
11. M Rajabi C Kassiotis P Razeghi H Taegtmeyer 2007 Return to the fetal gene program protects the stressed heart: a strong hypothesis Heart Fail Rev 12 331 343 1:CAS:528:DC%2BD2sXnvFKnt7o%3D 10.1007/s10741-007-9034-1 17516164 (Pubitemid 350176706)
12. JR Neely HE Morgan 1974 Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle Annu Rev Physiol 36 413 459 1:CAS:528:DyaE2cXkt1egsbg%3D 10.1146/annurev.ph.36.030174.002213 19400669
13. WC Stanley GD Lopaschuk JL Hall JG McCormack 1997 Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions Cardiovasc Res 33 243 257 1:CAS:528:DyaK2sXhvVSmsL0%3D 10.1016/S0008-6363(96)00245-3 9074687 (Pubitemid 27072627)
14. MP Chandler PN Chavez TA McElfresh H Huang CS Harmon WC Stanley 2003 Partial inhibition of fatty acid oxidation increases regional contractile power and efficiency during demand-induced ischemia Cardiovasc Res 59 143 151 1:CAS:528:DC%2BD3sXkvVKisbs%3D 10.1016/S0008-6363(03)00327-4 12829185 (Pubitemid 36776380)
15. K Abozguia K Clarke L Lee M Frenneaux 2006 Modification of myocardial substrate use as a therapy for heart failure Nat Clin Pract Cardiovasc Med 3 490 498 1:CAS:528:DC%2BD28XpvFegsbs%3D 10.1038/ncpcardio0583 16932766 (Pubitemid 44288462)
16. D Saito H Tani S Kusachi S Uchida N Ohbayashi M Marutani K Maekawa T Tsuji S Haraoka 1991 Oxygen metabolism of the hypertrophic right ventricle in open chest dogs Cardiovasc Res 25 731 739 1:STN:280:DyaK387ptFaguw%3D%3D 10.1093/cvr/25.9.731 1839241
17. SP Bishop RA Altschuld 1970 Increased glycolytic metabolism in cardiac hypertrophy and congestive failure Am J Physiol 218 153 159 1:CAS:528: DyaE3cXltlSiug%3D%3D 4243400
18. J Nagendran V Gurtu DZ Fu JR Dyck A Haromy DB Ross IM Rebeyka ED Michelakis 2008 A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targeted J Thorac Cardiovasc Surg 136 168 178 10.1016/j.jtcvs.2008.01.040 18603070 178 e161-163
19. S Sharma H Taegtmeyer J Adrogue P Razeghi S Sen K Ngumbela MF Essop 2004 Dynamic changes of gene expression in hypoxia-induced right ventricular hypertrophy Am J Physiol Heart Circ Physiol 286 H1185 H1192 1:CAS:528: DC%2BD2cXitlShtrk%3D 10.1152/ajpheart.00916.2003 14630626
20. Y Kim H Goto K Kobayashi Y Sawada Y Miyake G Fujiwara H Chiba T Okada T Nishimura 1997 Detection of impaired fatty acid metabolism in right ventricular hypertrophy: assessment by I-123 beta-methyl iodophenyl pentadecanoic acid (BMIPP) myocardial single-photon emission computed tomography Ann Nucl Med 11 207 212 1:CAS:528:DyaK2sXntVCltb0%3D 10.1007/BF03164765 9310169
21. HP Buermans EM Redout AE Schiel RJ Musters M Zuidwijk PP Eijk C van Hardeveld S Kasanmoentalib FC Visser B Ylstra WS Simonides 2005 Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure Physiol Genomics 21 314 323 1:CAS:528:DC%2BD2MXpvFOltbs%3D 10.1152/ physiolgenomics.00185.2004 15728335 (Pubitemid 40898491)
22. E Do S Baudet M Verdys C Touzeau F Bailly B Lucas-Heron M Sagniez A Rossi J Noireaud 1997 Energy metabolism in normal and hypertrophied right ventricle of the ferret heart J Mol Cell Cardiol 29 1903 1913 1:CAS:528:DyaK2sXltVOqsr8%3D 10.1006/jmcc.1997.0429 9236144 (Pubitemid 27303095)
23. T Daicho T Yagi Y Abe M Ohara T Marunouchi S Takeo K Tanonaka 2009 Possible involvement of mitochondrial energy-producing ability in the development of right ventricular failure in monocrotaline-induced pulmonary hypertensive rats J Pharmacol Sci 111 33 43 1:CAS:528:DC%2BD1MXht1ert7vL 10.1254/jphs.08322FP 19763046
24. C Antzelevitch 2007 Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes Europace 9 Suppl 4 iv4 iv15 10.1093/europace/eum166 17766323
25. JK Lee I Kodama H Honjo T Anno K Kamiya J Toyama 1997 Stage-dependent changes in membrane currents in rats with monocrotaline-induced right ventricular hypertrophy Am J Physiol 272 H2833 H2842 1:CAS:528: DyaK2sXksVSkurg%3D 9227563
26. T Hlaing D Guo X Zhao T DiMino L Greenspon PR Kowey GX Yan 2005 The QT and Tp-e intervals in left and right chest leads: comparison between patients with systemic and pulmonary hypertension J Electrocardiol 38 154 158 10.1016/j.jelectrocard.2005.06.028 16226092 (Pubitemid 41436505)
27. JK Lee A Nishiyama F Kambe H Seo S Takeuchi K Kamiya I Kodama J Toyama 1999 Downregulation of voltage-gated K(+) channels in rat heart with right ventricular hypertrophy Am J Physiol 277 H1725 H1731 1:CAS:528: DyaK1MXns1yrs7o%3D 10564125
28. TT Zhang B Cui DZ Dai 2004 Downregulation of Kv4.2 and Kv4.3 channel gene expression in right ventricular hypertrophy induced by monocrotaline in rat Acta Pharmacol Sin 25 226 230 1:CAS:528:DC%2BD2cXhsVSqsbk%3D 14769214
29. GJ Vlahakes K Turley JI Hoffman 1981 The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations Circulation 63 87 95 1:STN:280:DyaL3M%2FmsFWmsQ%3D%3D 7438411
30. M Kurzyna J Zylkowska A Fijalkowska M Florczyk M Wieteska A Kacprzak J Burakowski M Szturmowicz L Wawrzynska A Torbicki 2008 Characteristics and prognosis of patients with decompensated right ventricular failure during the course of pulmonary hypertension Kardiol Pol 66 1033 1039 19006024 discussion 1040-1031
31. C Partovian S Adnot S Eddahibi E Teiger M Levame P Dreyfus B Raffestin C Frelin 1998 Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension Am J Physiol 275 H1948 H1956 1:CAS:528:DyaK1MXht1Ogug%3D%3D 9843792
32. RM Graham DP Frazier JW Thompson S Haliko H Li BJ Wasserlauf MG Spiga NH Bishopric KA Webster 2004 A unique pathway of cardiac myocyte death caused by hypoxia-acidosis J Exp Biol 207 3189 3200 1:CAS:528:DC%2BD2cXovF2ku74%3D 10.1242/jeb.01109 15299040 (Pubitemid 39275293)
33. CV Dang JW Kim P Gao J Yustein 2008 The interplay between MYC and HIF in cancer Nat Rev Cancer 8 51 56 1:CAS:528:DC%2BD2sXhsVKku73K 10.1038/nrc2274 18046334
34. EM Redout MJ Wagner MJ Zuidwijk C Boer RJ Musters C van Hardeveld WJ Paulus WS Simonides 2007 Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species Cardiovasc Res 75 770 781 1:CAS:528:DC%2BD2sXpt1Srsr8%3D 10.1016/j.cardiores. 2007.05.012 17582388 (Pubitemid 47243719)
35. PS Pollack SR Houser R Budjak B Goldman 1994 c-myc gene expression is localized to the myocyte following hemodynamic overload in vivo J Cell Biochem 54 78 84 10.1002/jcb.240540109 1:CAS:528:DyaK2cXhtlWitbY%3D 10.1002/jcb. 240540109 8126088
36. W Zhong S Mao S Tobis E Angelis MC Jordan KP Roos MC Fishbein IM de Alboran WR MacLellan 2006 Hypertrophic growth in cardiac myocytes is mediated by Myc through a cyclin D2-dependent pathway EMBO J 25 3869 3879 1:CAS:528:DC%2BD28XovVSqurY%3D 10.1038/sj.emboj.7601252 16902412 (Pubitemid 44300272)
37. JS Jaswal M Gandhi BA Finegan JR Dyck AS Clanachan 2007 Inhibition of p38 MAPK and AMPK restores adenosine-induced cardioprotection in hearts stressed by antecedent ischemia by altering glucose utilization Am J Physiol Heart Circ Physiol 293 H1107 H1114 1:CAS:528:DC%2BD2sXptlyku7k%3D 10.1152/ajpheart.00455. 2007 17496214 (Pubitemid 47254211)
38. MC Sugden ML Langdown RA Harris MJ Holness 2000 Expression and regulation of pyruvate dehydrogenase kinase isoforms in the developing rat heart and in adulthood: role of thyroid hormone status and lipid supply Biochem J 352 Pt 3 731 738 1:CAS:528:DC%2BD3MXkvVSltQ%3D%3D 10.1042/0264-6021:3520731 11104680 (Pubitemid 32015029)
39. ED Michelakis MS McMurtry XC Wu JR Dyck R Moudgil TA Hopkins GD Lopaschuk L Puttagunta R Waite SL Archer 2002 Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels Circulation 105 244 250 1:CAS:528:DC%2BD38XhsFeksL0%3D 10.1161/hc0202.101974 11790708 (Pubitemid 34084326)
40. Z Grabczewska T Bialoszynski P Szymanski A Sukiennik I Swiatkiewicz M Kozinski W Kochman G Grzesk J Kubica 2008 The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease Cardiol J 15 344 350 18698543
41. Y Gunes U Guntekin M Tuncer M Sahin 2009 Improved left and right ventricular functions with trimetazidine in patients with heart failure: a tissue Doppler study Heart Vessels 24 277 282 10.1007/s00380-008-1118-x 19626400
42. PF Kantor A Lucien R Kozak GD Lopaschuk 2000 The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase Circ Res 86 580 588 1:CAS:528:DC%2BD3cXitFWgsrk%3D 10720420
43. GM Rosano C Vitale B Sposato G Mercuro M Fini 2003 Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study Cardiovasc Diabetol 2 16 10.1186/1475-2840-2-16 14641923 (Pubitemid 38751097)
44. H Tuunanen E Engblom A Naum K Nagren M Scheinin B Hesse KE Juhani Airaksinen P Nuutila P Iozzo H Ukkonen LH Opie J Knuuti 2008 Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy Circulation 118 1250 1258 1:CAS:528:DC%2BD1cXhtV2isbzF 10.1161/CIRCULATIONAHA.108.778019 18765391
45. G Fragasso R Spoladore A Cuko A Palloshi 2007 Modulation of fatty acids oxidation in heart failure by selective pharmacological inhibition of 3-ketoacyl coenzyme-A thiolase Curr Clin Pharmacol 2 190 196 1:CAS:528:DC%2BD2sXhtVWgurrI 10.2174/157488407781668776 18690865 (Pubitemid 47520957)
46. WC Stanley 2002 Partial fatty acid oxidation inhibitors for stable angina Expert Opin Investig Drugs 11 615 629 1:CAS:528:DC%2BD38XjvVGgsbw%3D 10.1517/13543784.11.5.615 11996644 (Pubitemid 34520613)
47. P Wang H Fraser SG Lloyd JJ McVeigh L Belardinelli JC Chatham 2007 A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion J Pharmacol Exp Ther 321 213 220 1:CAS:528:DC%2BD2sXktVSksbg%3D 10.1124/jpet.106.115519 17202401 (Pubitemid 46456960)
48. B Clarke KM Wyatt JG McCormack 1996 Ranolazine increases active pyruvate dehydrogenase in perfused normoxic rat hearts: evidence for an indirect mechanism J Mol Cell Cardiol 28 341 350 1:CAS:528:DyaK28Xht1emsLk%3D 10.1006/jmcc.1996.0032 8729066 (Pubitemid 26110478)
49. JG McCormack RL Barr AA Wolff GD Lopaschuk 1996 Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts Circulation 93 135 142 1:CAS:528:DyaK28XhtVyhsrs%3D 8616920
50. I Samudio R Harmancey M Fiegl H Kantarjian M Konopleva B Korchin K Kaluarachchi W Bornmann S Duvvuri H Taegtmeyer M Andreeff 2010 Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction J Clin Invest 120 142 156 1:CAS:528:DC%2BC3cXislWnug%3D%3D 10.1172/JCI38942 20038799
51. AI Undrovinas L Belardinelli NA Undrovinas HN Sabbah 2006 Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current J Cardiovasc Electrophysiol 17 Suppl 1 S169 S177 10.1111/j.1540-8167.2006.00401.x 16686675
52. A Aaker JG McCormack T Hirai TI Musch 1996 Effects of ranolazine on the exercise capacity of rats with chronic heart failure induced by myocardial infarction J Cardiovasc Pharmacol 28 353 362 1:CAS:528:DyaK28XlsFegu7w%3D 10.1097/00005344-199609000-00002 8877580 (Pubitemid 26317432)
53. EM Redout A van der Toorn MJ Zuidwijk CW van de Kolk CJ van Echteld RJ Musters C van Hardeveld WJ Paulus WS Simonides 2010 Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure Am J Physiol Heart Circ Physiol 298 H1038 H1047 1:CAS:528:DC%2BC3cXjsFGns7k%3D 10.1152/ajpheart.00097.2009 20061549